Nguyen Tran

9PUBLICATIONS
60CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 10, 2026
Long-Term Outcomes and Surgical Conversion After Immunotherapy in Microsatellite Instability-H Biliary Tract Cancers.

|Jun 01, 2026
Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase III FIGHT-302 Trial.

|Nov 20, 2025
Immune Checkpoint Inhibitors for Mismatch Repair-Deficient Gastroesophageal Adenocarcinoma: Outcomes and Feasibility of Nonoperative Management at Mayo Clinic.

Oudai Sahwan, Fares Jamal, Rish Pai

|Dec 14, 2024
Second-line therapies in advanced hepatocellular carcinoma following first-line atezolizumab and bevacizumab: multicenter single institution cohort experience.

Paulina Marell, Ioannis Kournoutas, Jennifer Gile

|Jan 18, 2024
Tumor-Informed Circulating Tumor DNA for Minimal Residual Disease Detection in the Management of Colorectal Cancer.

Oluwadunni E Emiloju, Michael Storandt, Tyler Zemla

|Nov 11, 2022
Cabozantinib Following Immunotherapy in Patients with Advanced Hepatocellular Carcinoma.

Michael H Storandt, Jennifer J Gile, Mathias E Palmer

Pageof 2

Frequent Collaborators

5 joint publications

Mitesh J Borad

5 joint publications

Amit Mahipal

4 joint publications

Zhaohui Jin

4 joint publications

Tanios S Bekaii-Saab